Emtricitabine And Tenofovir Disoproxil Fumarate
Product Images NDC 67296-1440

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 67296-1440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (200 mg/300 mg (30 Tablet Bottle))

Label for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg, showing the active ingredient strengths. The label includes storage instructions, distributor info for Aurobindo Pharma USA, Inc., and a package count of 30 tablets. It advises pharmacists to dispense the medication guide separately and notes the product is made in India.*

FDA Label Image

Chemical Structure-1 (Emtriteno Str1)

Chemical structure of Emtricitabine, one of the active ingredients in Emtricitabine and Tenofovir Disoproxil Fumarate. The diagram shows atoms and bonds including nitrogen, oxygen, fluorine, sulfur, and carbon arranged in a molecular configuration.*

FDA Label Image

Chemical Structure-2 (Emtriteno Str2)

Chemical structure of Emtricitabine and Tenofovir Disoproxil Fumarate, showing the molecular arrangements of both active ingredients in the combination drug by Redpharm Drug, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.